Skip to main content
Top
Published in: BMC Pregnancy and Childbirth 1/2022

Open Access 01-12-2022 | Research

Fetal congenital heart disease - mode of delivery and obstetrical complications

Authors: Keren Zloto, Alyssa Hochberg, Kinneret Tenenbaum-Gavish, Alexandra Berezowsky, Shiri Barbash-Hazan, Ron Bardin, Eran Hadar, Anat Shmueli

Published in: BMC Pregnancy and Childbirth | Issue 1/2022

Login to get access

Abstract

Background

The optimal mode of delivery in cases of fetal congenital heart disease (CHD) is not established. The few relevant studies did not address operative vaginal delivery. The aim of this study was to assess the impact of fetal CHD on mode of delivery during a trial of labor, and to secondarily describe some obstetric complications.

Methods

The database of a tertiary medical center was searched for women who gave birth to a singleton, liveborn neonate in 2015–2018. Mode of delivery was compared between women carrying a fetus with known CHD and women with a healthy fetus matched 1:5 for maternal age, parity, body mass index, and gestational age.

Results

The cohort included 616 women, 105 in the CHD group and 511 in the control group. The rate of operative vaginal delivery was significantly higher in the CHD group (18.09% vs 9.78%, OR 2.03, 95% CI 1.13–3.63, p = 0.01); the difference remained significant after adjustment for nulliparity and gestational age at delivery (aOR 2.58, 95% CI 1.36–4.9, p < 0.01). There was no difference between the CHD and control group in rate of intrapartum cesarean delivery (9.52% vs 10.76%, respectively, OR 0.97, 95% CI 0.47–1.98, p = 0.93). The most common indication for operative vaginal delivery was non-reassuring fetal heart rate (78.94% vs 64%, respectively). Median birth weight percentile was significantly lower in the CHD group (45th vs 53rd percentile, p = 0.04).

Conclusions

Our findings suggest that operative vaginal delivery, performed mostly because of non-reassuring fetal heart rate, is more common in pregnancies complicated by a prenatal diagnosis of CHD than non-anomalous pregnancies.
Literature
1.
go back to reference Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900.CrossRef Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39(12):1890–900.CrossRef
2.
go back to reference Parikh LI, Grantz KL, Iqbal SN, et al. Neonatal outcomes in fetuses with cardiac anomalies and the impact of delivery route. Am J Obstet Gynecol. 2017;217(4):469.e1–469.e12.CrossRef Parikh LI, Grantz KL, Iqbal SN, et al. Neonatal outcomes in fetuses with cardiac anomalies and the impact of delivery route. Am J Obstet Gynecol. 2017;217(4):469.e1–469.e12.CrossRef
3.
go back to reference Bouma BJ, Mulder BJ. Changing landscape of congenital heart disease. Circ Res. 2017;120(6):908–22.CrossRef Bouma BJ, Mulder BJ. Changing landscape of congenital heart disease. Circ Res. 2017;120(6):908–22.CrossRef
4.
go back to reference Khan A, Gurvitz M. Epidemiology of ACHD: what has changed and what is changing? Prog Cardiovasc Dis. 2018;61(3–4):275–81.CrossRef Khan A, Gurvitz M. Epidemiology of ACHD: what has changed and what is changing? Prog Cardiovasc Dis. 2018;61(3–4):275–81.CrossRef
5.
go back to reference Stoll C, Tenconi R, Clementi M. Detection of congenital anomalies by fetal ultrasonographic examination across Europe. Community Genet. 2001;4(4):225–32.PubMed Stoll C, Tenconi R, Clementi M. Detection of congenital anomalies by fetal ultrasonographic examination across Europe. Community Genet. 2001;4(4):225–32.PubMed
6.
go back to reference Garne E, Loane M, Dolk H, et al. Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol. 2005;25(1):6–11.CrossRef Garne E, Loane M, Dolk H, et al. Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol. 2005;25(1):6–11.CrossRef
7.
go back to reference van Velzen CL, Clur SA, Rijlaarsdam ME, et al. Prenatal detection of congenital heart disease--results of a national screening programme. BJOG. 2016;123(3):400–7.CrossRef van Velzen CL, Clur SA, Rijlaarsdam ME, et al. Prenatal detection of congenital heart disease--results of a national screening programme. BJOG. 2016;123(3):400–7.CrossRef
8.
go back to reference Mellander M. Perinatal management, counselling and outcome of fetuses with congenital heart disease. Semin Fetal Neonatal Med. 2005;10(6):586–93.CrossRef Mellander M. Perinatal management, counselling and outcome of fetuses with congenital heart disease. Semin Fetal Neonatal Med. 2005;10(6):586–93.CrossRef
9.
go back to reference Jowett VC, Sankaran S, Rollings SL, Hall R, Kyle PM, Sharland GK. Foetal congenital heart disease: obstetric management and time to first cardiac intervention in babies delivered at a tertiary Centre. Cardiol Young. 2014;24(3):494–502.CrossRef Jowett VC, Sankaran S, Rollings SL, Hall R, Kyle PM, Sharland GK. Foetal congenital heart disease: obstetric management and time to first cardiac intervention in babies delivered at a tertiary Centre. Cardiol Young. 2014;24(3):494–502.CrossRef
10.
go back to reference Trento LU, Pruetz JD, Chang RK, Detterich J, Sklansky MS. Prenatal diagnosis of congenital heart disease: impact of mode of delivery on neonatal outcome. Prenat Diagn. 2012;32(13):1250–5.CrossRef Trento LU, Pruetz JD, Chang RK, Detterich J, Sklansky MS. Prenatal diagnosis of congenital heart disease: impact of mode of delivery on neonatal outcome. Prenat Diagn. 2012;32(13):1250–5.CrossRef
11.
go back to reference Peyvandi S, Nguyen TA, Almeida-Jones M, et al. University of California Fetal Consortium (UCfC). Timing and mode of delivery in prenatally diagnosed congenital heart disease- an analysis of practices within the University of California Fetal Consortium (UCfC). Pediatr Cardiol. 2017;38(3):588–95.CrossRef Peyvandi S, Nguyen TA, Almeida-Jones M, et al. University of California Fetal Consortium (UCfC). Timing and mode of delivery in prenatally diagnosed congenital heart disease- an analysis of practices within the University of California Fetal Consortium (UCfC). Pediatr Cardiol. 2017;38(3):588–95.CrossRef
12.
go back to reference Landis BJ, Levey A, Levasseur SM, et al. Prenatal diagnosis of congenital heart disease and birth outcomes. Pediatr Cardiol. 2013;34(3):597–605.CrossRef Landis BJ, Levey A, Levasseur SM, et al. Prenatal diagnosis of congenital heart disease and birth outcomes. Pediatr Cardiol. 2013;34(3):597–605.CrossRef
13.
go back to reference Asoglu MR, Bears B, Turan S, Harman C, Turan OM. The factors associated with mode of delivery in fetuses with congenital heart defects. J Matern Fetal Neonatal Med. 2020;33(5):816–24.CrossRef Asoglu MR, Bears B, Turan S, Harman C, Turan OM. The factors associated with mode of delivery in fetuses with congenital heart defects. J Matern Fetal Neonatal Med. 2020;33(5):816–24.CrossRef
14.
go back to reference Gould JB, Danielsen B, Korst LM, et al. Cesarean delivery rates and neonatal morbidity in a low-risk population. Obstet Gynecol. 2004;104(1):11–9.CrossRef Gould JB, Danielsen B, Korst LM, et al. Cesarean delivery rates and neonatal morbidity in a low-risk population. Obstet Gynecol. 2004;104(1):11–9.CrossRef
15.
go back to reference Cai M, Loy SL, Tan KH, et al. Association of elective and emergency cesarean delivery with early childhood overweight at 12 months of age. JAMA Netw Open. 2018;1(7):e185025.CrossRef Cai M, Loy SL, Tan KH, et al. Association of elective and emergency cesarean delivery with early childhood overweight at 12 months of age. JAMA Netw Open. 2018;1(7):e185025.CrossRef
16.
go back to reference Villar J, Carroli G, Zavaleta N, et al. World Health Organization 2005 global survey on maternal and perinatal Health Research Group. Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study. BMJ. 2007;335(7628):1025.CrossRef Villar J, Carroli G, Zavaleta N, et al. World Health Organization 2005 global survey on maternal and perinatal Health Research Group. Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study. BMJ. 2007;335(7628):1025.CrossRef
17.
go back to reference Levi S, Zhang WH, Alexander S, Viart P, Grandjean H. Eurofetus study group. Short-term outcome of isolated and associated congenital heart defects in relation to antenatal ultrasound screening. Ultrasound Obstet Gynecol. 2003;21(6):532–8.CrossRef Levi S, Zhang WH, Alexander S, Viart P, Grandjean H. Eurofetus study group. Short-term outcome of isolated and associated congenital heart defects in relation to antenatal ultrasound screening. Ultrasound Obstet Gynecol. 2003;21(6):532–8.CrossRef
18.
go back to reference Walsh CA, MacTiernan A, Farrell S, et al. Mode of delivery in pregnancies complicated by major fetal congenital heart disease: a retrospective cohort study. J Perinatol. 2014;34(12):901–5.CrossRef Walsh CA, MacTiernan A, Farrell S, et al. Mode of delivery in pregnancies complicated by major fetal congenital heart disease: a retrospective cohort study. J Perinatol. 2014;34(12):901–5.CrossRef
19.
go back to reference Ge CJ, Mahle AC, Burd I, Jelin EB, Sekar P, Jelin AC. Fetal CHD and perinatal outcomes. Cardiol Young. 2020;30(5):686–91.CrossRef Ge CJ, Mahle AC, Burd I, Jelin EB, Sekar P, Jelin AC. Fetal CHD and perinatal outcomes. Cardiol Young. 2020;30(5):686–91.CrossRef
20.
go back to reference Cedergren MI, Källén BA. Obstetric outcome of 6346 pregnancies with infants affected by congenital heart defects. Eur J Obstet Gynecol Reprod Biol. 2006;125(2):211–6.CrossRef Cedergren MI, Källén BA. Obstetric outcome of 6346 pregnancies with infants affected by congenital heart defects. Eur J Obstet Gynecol Reprod Biol. 2006;125(2):211–6.CrossRef
22.
go back to reference Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr. 2008;153(6):807–13.CrossRef Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr. 2008;153(6):807–13.CrossRef
23.
go back to reference Peterson AL, Quartermain MD, Ades A, Khalek N, Johnson MP, Rychik J. Impact of mode of delivery on markers of perinatal hemodynamics in infants with hypoplastic left heart syndrome. J Pediatr. 2011;159(1):64–9.CrossRef Peterson AL, Quartermain MD, Ades A, Khalek N, Johnson MP, Rychik J. Impact of mode of delivery on markers of perinatal hemodynamics in infants with hypoplastic left heart syndrome. J Pediatr. 2011;159(1):64–9.CrossRef
24.
go back to reference Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birth weight standards in the live-born population in Israel. Isr Med Assoc J. 2005;7(5):311–4.PubMed Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birth weight standards in the live-born population in Israel. Isr Med Assoc J. 2005;7(5):311–4.PubMed
25.
go back to reference Ueda K, Ikeda T, Iwanaga N, et al. Intrapartum fetal heart rate monitoring in cases of congenital heart disease. Am J Obstet Gynecol. 2009;201(1):64.e1–6.CrossRef Ueda K, Ikeda T, Iwanaga N, et al. Intrapartum fetal heart rate monitoring in cases of congenital heart disease. Am J Obstet Gynecol. 2009;201(1):64.e1–6.CrossRef
Metadata
Title
Fetal congenital heart disease - mode of delivery and obstetrical complications
Authors
Keren Zloto
Alyssa Hochberg
Kinneret Tenenbaum-Gavish
Alexandra Berezowsky
Shiri Barbash-Hazan
Ron Bardin
Eran Hadar
Anat Shmueli
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2022
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-022-04910-w

Other articles of this Issue 1/2022

BMC Pregnancy and Childbirth 1/2022 Go to the issue